SCHEMBL4880

SCHEMBL4880

CC(=O)N1CC[N]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL714789 0.91 CYP1A2 (0.44)
SCHEMBL3031054 0.91 CYP1A2 (0.50)
SCHEMBL8192649 0.85 TDP1 (0.45)
SCHEMBL7347788 0.84
SCHEMBL6624474 0.79 CYP1A2 (0.32)
SCHEMBL14407779 0.78 CYP1A2 (0.77)
SCHEMBL860793 0.78 CYP1A2 (0.77)
SCHEMBL37407 0.78
SCHEMBL1812992 0.75 CHRNB2 (0.41)
SCHEMBL9533757 0.75 JAK3 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2623 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400491-A1 NOVEL LIPIDS USED FOR NUCLEIC ACID DELIVERY AND LIPID NANOPARTICLE COMPOSITION Themedium Therapeutics Co., Ltd (CN) 2024-07-17 EP claimed
EP-4389746-A2 P2X3 RECEPTOR ANTAGONISTS Recordati Industria Chimica E Farmaceutica SPA (IT) 2024-06-26 EP claimed
US-20240197888-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2024-06-20 US claimed
CN-115108931-B Tofenamic acid derivative and preparation and application thereof 南华大学附属第一医院 2024-06-14 CN claimed
US-20240190885-A1 KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX INC (US) 2024-06-13 US claimed
US-11999732-B2 P2X3 receptor antagonists RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (IT) 2024-06-04 US claimed
WO-2024109794-A1 NOVEL LIPIDS USED FOR NUCLEIC ACID DELIVERY AND LIPID NANOPARTICLE COMPOSITION 传信生物医药(苏州)有限公司 2024-05-30 WO claimed
US-20240124474-A1 HER2 MUTATION INHIBITORS ARRAY BIOPHARMA INC. (US) 2024-04-18 US claimed
EP-3498716-B1 SULFONYL BEARING THIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATION AS ANTI-CANCER AGENT UNIV XIAMEN (CN) 2024-04-17 EP claimed
CN-117794923-A Benzodioxane compound, and preparation method and application thereof 南京红云生物科技有限公司 2024-03-29 CN claimed
US-4472395-A PLANT SAFENING AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1984-09-18 US claimed
US-4470994-A DIOXOLANE OR DIOXANE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1984-09-11 US claimed
EP-0110298-A1 Acridanone derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-06-13 EP claimed
EP-0057863-B1 ANTIMICROBIAL AGENT BAYER AG (DE) 1984-06-13 EP claimed
EP-0057863-A2 Antimicrobial agent BAYER AG (DE) 1982-08-18 EP claimed
EP-0057864-A2 2-Azolylmethyl-1,3-dioxolane and dioxane derivatives, process for their preparation and their application as fungicides BAYER AG (DE) 1982-08-18 EP claimed
EP-0035172-A2 Process for dyeing the fleeces of skins BASF Aktiengesellschaft (DE) 1981-09-09 EP claimed
US-4154828-A ANTITHROMBOGENIC MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1979-05-15 US claimed
US-4133880-A ANTICOAGULANTS MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1979-01-09 US claimed
US-3939268-A 2,4-Diamino substituted pyridol(3,2-d)pyrimidine as antithrombotic agents BOEHRINGER INGELHEIM GMBH (DT) 1976-02-17 US claimed